Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
6 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Nexalin Technology, Inc.’s names, not what it holds today.
Patents granted
6
4 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
3
Against 3 in 2024 and none in 2023
Applications published
8
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Nexalin Technology, Inc. its own name
named as the applicant on its applications, in US
8 publishedNEXALIN TECHNOLOGY, INC. its own name
US, as the owner printed on each patent
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Sep 9, 2025 | D1,092,758 | Transcranial electro-stimulation device | | NEXALIN TECHNOLOGY, INC. |
| Apr 29, 2025 | D1,073,092 | Transcranial electro-stimulation device | | NEXALIN TECHNOLOGY, INC. |
| Apr 1, 2025 | 12,263,336 | Alternating current dynamic frequency stimulation system and method for opioid use disorder (OUD) and substance use disorder (SUD) | Medical technology | NEXALIN TECHNOLOGY, INC. |
| Jun 18, 2024 | 12,011,591 | Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimers and dementia | Medical technology | NEXALIN TECHNOLOGY, INC. |
| Apr 2, 2024 | 11,944,806 | Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia (ADI) | Medical technology | NEXALIN TECHNOLOGY, INC. |
| Jan 16, 2024 | 11,872,397 | Transcranial alternating current dynamic frequency stimulation (TACS) system | Medical technology | NEXALIN TECHNOLOGY, INC. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Mar 27, 2025 | 2025/0099756 | PASSIVE ELECTRICAL NEUROFEEDBACK TREATMENT METHOD FOR MILD TRAUMATIC BRAIN INJURY AND POST-CONCUSSION SYMPTOMS | Medical technology | Nexalin Technology, Inc. |
| Aug 29, 2024 | 2024/0285943 | TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM | Medical technology | Nexalin Technology, Inc. |
| Jun 13, 2024 | 2024/0189590 | TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION METHOD FOR ANXIETY, DEPRESSION, AND INSOMNIA (ADI) | Medical technology | Nexalin Technology, Inc. |
| Nov 30, 2023 | 2023/0381510 | TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) METHOD FOR ALZHEIMERS AND DEMENTIA | Medical technology | Nexalin Technology, Inc. · patent 12,011,591 granted from it |
| Jun 22, 2023 | 2023/0191125 | TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA | Medical technology | Nexalin Technology, Inc. · patent 11,872,397 granted from it |
| Jan 27, 2022 | 2022/0023629 | TRANSCRANIAL ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA | Medical technology | Nexalin Technology, Inc. · patent 11,872,397 granted from it |
| Jan 27, 2022 | 2022/0023616 | ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION SYSTEM AND METHOD FOR OPIOID USE DISORDER (OUD) AND SUBSTANCE USE DISORDER (SUD) | Medical technology | Nexalin Technology, Inc. · patent 12,263,336 granted from it |
| Jan 27, 2022 | 2022/0023615 | ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION SYSTEM AND METHOD FOR ANXIETY, DEPRESSION, AND INSOMNIA (ADI) | Medical technology | Nexalin Technology, Inc. · patent 11,944,806 granted from it |
What it applied for, 2024 to 2025: Medical technology 3.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.